Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature

Dupilumab, a biologic drug approved for the treatment of moderate‐to‐severe atopic dermatitis, has been associated with resolution or improvement in pre‐existing alopecia areata. We report a case of significant improvement of AA after Dupilumab‐onset treatment for atopic dermatitis and review the li...

Full description

Saved in:
Bibliographic Details
Published in:Australasian journal of dermatology 2020-05, Vol.61 (2), p.e223-e225
Main Authors: Magdaleno‐Tapial, Jorge, Valenzuela‐Oñate, Cristian, García‐Legaz‐Martínez, Marta, Martínez‐Domenech, Álvaro, Pérez‐Ferriols, Amparo
Format: Article
Language:English
Subjects:
Adult
Alopecia
alopecia areata
Alopecia Areata - complications
Alopecia Areata - drug therapy
Antibodies, Monoclonal, Humanized - therapeutic use
Atopic dermatitis
Baldness
Case reports
Dermatitis
Dermatitis, Atopic - complications
Dermatitis, Atopic - drug therapy
dupilumab
Follow-Up Studies
Humans
Immunotherapy
Male
Monoclonal antibodies
treatment
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dupilumab, a biologic drug approved for the treatment of moderate‐to‐severe atopic dermatitis, has been associated with resolution or improvement in pre‐existing alopecia areata. We report a case of significant improvement of AA after Dupilumab‐onset treatment for atopic dermatitis and review the literature.
ISSN:0004-8380
1440-0960
DOI:10.1111/ajd.13208